Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Spine Surgery May not Be Needed to Ease Back Pain from Osteoporosis

Lisa Rapaport  |  June 3, 2018

One limitation of the study is that it lacked a control group of patients who received non-surgical treatments like painkillers, back braces or bed rest, researchers note in The BMJ.

Another drawback is that all of the patients had recent fractures, making it unclear if results would be similar for people who had chronic pain many months after fractures developed. It’s also possible that some patients in the study experienced chronic back pain unrelated to compression fractures and caused instead by damaged discs or other issues.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Still, the results suggest that patients should not consider vertebroplasty for fractures that happened only a month or two ago, Davies said by email.

“You don’t need a vertebroplasty under nine weeks following onset of pain, because for most people the pain just gets better,” Davies said. “If the pain doesn’t improve and imaging suggests the fracture hasn’t healed then it may be appropriate.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Firanescu CE, de Vries J, Lodder P, et al. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compressionfractures (VERTOS IV): randomised sham controlled clinical trial. BMJ. 2018 May 9;361:k1551.

 

 

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Back painCristina FiranescuEvan DaviesOsteoporosisspine surgery

Related Articles

    Is Acupuncture for Pain a Placebo Treatment?

    November 1, 2010

    An examination of the evidence

    Case Report: Rheumatoid Arthritis Complicated by Large Granular Lymphocytic Leukemia

    November 14, 2021

    Large granular lymphocytic (LGL) leukemia is a rare, chronic, lymphoproliferative disorder of cytotoxic T cell or natural killer cell lineage with an annual incidence of 0.72 cases per 1 million people in the U.S.1 The most common sub­type of LGL leukemia, T-LGL leukemia, follows an indolent disease course and accounts for approximately 85% of cases….

    Concrete Relief for Vertebral Fractures

    April 1, 2008

    PVA reduces fracture pain—but is it overused?

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences